Stay updated on Tetravalent Dengue Vaccine Booster in Completed Schedule Clinical Trial
Sign up to get notified when there's something new on the Tetravalent Dengue Vaccine Booster in Completed Schedule Clinical Trial page.

Latest updates to the Tetravalent Dengue Vaccine Booster in Completed Schedule Clinical Trial page
- Check7 days agoChange DetectedThe screenshots show the same study record for NCT02824198 with no changes to core content such as objectives, eligibility, or outcomes; only minor layout/formatting differences appear. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check14 days agoNo Change Detected
- Check36 days agoChange DetectedSite now includes a government funding notice and current NIH Clinical Center operating status, plus a v3.2.0 release; Dengue resource entry and v3.1.0 tag removed.SummaryDifference3%

- Check43 days agoChange DetectedThe page shifts from drug-safety and solution-focused topics to chemistry-focused categories, adding new chemical-related entries and introducing revision v3.1.0 while removing several previous topics and the older revision v3.0.2.SummaryDifference0.9%

- Check57 days agoChange DetectedRevision updated to v3.0.2 from v3.0.1, indicating a minor version upgrade. The 'Back to Top' link was removed, a minor UI change with no substantive content updates.SummaryDifference0.2%

- Check64 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check72 days agoChange DetectedThe web page has undergone significant changes, including the addition of new facility and drug-related information, while removing various location and health-related terms.SummaryDifference3%

Stay in the know with updates to Tetravalent Dengue Vaccine Booster in Completed Schedule Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tetravalent Dengue Vaccine Booster in Completed Schedule Clinical Trial page.